Eslicarbazepine Acetate as Therapy in Post-Herpetic Neuralgia
Clinical trial NCT01124097 · TERMINATED
Trial details
- NCT number
- NCT01124097
- Sponsor
- Bial - Portela C S.A.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-01
- Primary completion
- 2012-04-01
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.